Healthcare Utilisation and Costs Associated with Adding Montelukast to Current Therapy in Patients with Mild to Moderate Asthma and Co-Morbid Allergic Rhinitis: PRAACTICAL Study

Author： Roberto Dal Negro  

Publisher： Adis International

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.25, Iss.8, 2007-01, pp. : 665-676

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Montelukast an advantage for asthma and allergic rhinitis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 518, 2006-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite

A review of montelukast in the treatment of asthma and allergic rhinitis

By Nayak Anjuli  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 3, 2004-03 ,pp. : 679-686

Informa Healthcare

Access to resources Recommend Favorite

Montelukast effective in managing allergic rhinitis

By  

Inpharma, Vol. 1, Iss. 1385, 2003-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Montelukast - creeping closer to the allergic rhinitis market

By  

Inpharma, Vol. 1, Iss. 1285, 2001-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

Intranasal fluticasone propionate superior to montelukast in allergic rhinitis

By  

Inpharma, Vol. 1, Iss. 1434, 2004-01 ,pp. : 11-12

Adis International

Access to resources Recommend Favorite